Swiss Life Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.3M | Buy |
60,525
+7,452
| +14% | +$3.58M | 0.13% | 135 |
|
|
2026
Q1 | $26.1M | Buy |
53,073
+6,272
| +13% | +$3.4M | 0.13% | 134 |
|
|
2025
Q4 | $27.1M | Buy |
46,801
+1,721
| +4% | +$973K | 0.14% | 122 |
|
|
2025
Q3 | $21.9M | Buy |
45,080
+2,007
| +5% | +$934K | 0.11% | 141 |
|
|
2025
Q2 | $17.5M | Buy |
43,073
+8,448
| +24% | +$3.53M | 0.1% | 156 |
|
|
2025
Q1 | $17.2M | Buy |
34,625
+5,156
| +17% | +$2.79M | 0.13% | 139 |
|
|
2024
Q4 | $15.3M | Buy |
29,469
+13,753
| +88% | +$7.56M | 0.11% | 138 |
|
|
2024
Q3 | $9.71M | Sell |
15,716
-3,454
| -18% | -$2.04M | 0.11% | 174 |
|
|
2024
Q2 | $10.6M | Buy |
19,170
+4,254
| +29% | +$2.44M | 0.13% | 153 |
|
|
2024
Q1 | $8.67M | Sell |
14,916
-42,258
| -74% | -$23.7M | 0.12% | 158 |
|
|
2023
Q4 | $30.4M | Buy |
57,174
+21,636
| +61% | +$10.5M | 0.36% | 50 |
|
|
2023
Q3 | $18M | Buy |
35,538
+558
| +2% | +$297K | 0.28% | 73 |
|
|
2023
Q2 | $18.3M | Sell |
34,980
-1,834
| -5% | -$990K | 0.27% | 74 |
|
|
2023
Q1 | $21.2M | Buy |
36,814
+5,712
| +18% | +$3.22M | 0.32% | 66 |
|
|
2022
Q4 | $17.1M | Sell |
31,102
-4,923
| -14% | -$2.61M | 0.29% | 81 |
|
|
2022
Q3 | $18.3M | Sell |
36,025
-1,020
| -3% | -$571K | 0.32% | 65 |
|
|
2022
Q2 | $20.1M | Sell |
37,045
-15,465
| -29% | -$8.51M | 0.33% | 68 |
|
|
2022
Q1 | $31M | Sell |
52,510
-7,146
| -12% | -$4.11M | 0.44% | 42 |
|
|
2021
Q4 | $39.8M | Buy |
59,656
+3,765
| +7% | +$2.35M | 0.52% | 34 |
|
|
2021
Q3 | $31.9M | Sell |
55,891
-5,657
| -9% | -$3.1M | 0.44% | 45 |
|
|
2021
Q2 | $40M | Sell |
61,548
-7,340
| -11% | -$3.46M | 0.4% | 34 |
|
|
2021
Q1 | $31.4M | Buy |
68,888
+82
| +0.1% | +$39.1K | 0.45% | 43 |
|
|
2020
Q4 | $32M | Buy |
68,806
+44,511
| +183% | +$20.9M | 0.47% | 40 |
|
|
2020
Q3 | $10.7M | Buy |
24,295
+14,824
| +157% | +$6.12M | 0.16% | 117 |
|
|
2020
Q2 | $3.43M | Buy |
9,471
+5,849
| +161% | +$1.96M | 0.06% | 228 |
|
|
2020
Q1 | $1.03M | Sell |
3,622
-30
| -0.8% | -$9.46K | 0.02% | 372 |
|
|
2019
Q4 | $1.19M | Buy |
3,652
+36
| +1% | +$10.9K | 0.02% | 383 |
|
|
2019
Q3 | $1.05M | Sell |
3,616
-179,621
| -98% | -$51.4M | 0.01% | 395 |
|
|
2019
Q2 | $53.8M | Sell |
183,237
-4,373
| -2% | -$1.2M | 0.65% | 37 |
|
|
2019
Q1 | $51.4M | Buy |
187,610
+250
| +0.1% | +$62.2K | 0.65% | 38 |
|
|
2018
Q4 | $41.9M | Buy |
187,360
+2,482
| +1% | +$582K | 0.85% | 30 |
|
|
2018
Q3 | $45.1M | Sell |
184,878
-3,963
| -2% | -$912K | 0.6% | 41 |
|
|
2018
Q2 | $39.1M | Sell |
188,841
-1,023
| -0.5% | -$217K | 0.59% | 44 |
|
|
2018
Q1 | $39.2M | Buy |
189,864
+1,247
| +0.7% | +$262K | 0.69% | 34 |
|
|
2017
Q4 | $35.8M | Buy |
188,617
+10,602
| +6% | +$2.03M | 0.8% | 32 |
|
|
2017
Q3 | $33.7M | Buy |
178,015
+8,825
| +5% | +$1.6M | 0.9% | 25 |
|
|
2017
Q2 | $29.5M | Hold |
169,190
| – | – | 0.76% | 26 |
|
|
2017
Q1 | $26M | Buy |
169,190
+13,603
| +9% | +$2.08M | 0.7% | 34 |
|
|
2016
Q4 | $22M | Buy |
155,587
+43,438
| +39% | +$6.4M | 0.74% | 41 |
|
|
2016
Q3 | $17.8M | Buy |
112,149
+2,942
| +3% | +$453K | 0.61% | 38 |
|
|
2016
Q2 | $16.1M | Hold |
109,207
| – | – | 0.66% | 37 |
|
|
2016
Q1 | $15.5M | Hold |
109,207
| – | – | 0.65% | 37 |
|
|
2015
Q4 | $15.5M | Sell |
109,207
-2,546
| -2% | -$340K | 0.69% | 32 |
|
|
2015
Q3 | $13.7M | Buy |
111,753
+10,236
| +10% | +$1.33M | 0.66% | 34 |
|
|
2015
Q2 | $13.2M | Sell |
101,517
-6,260
| -6% | -$816K | 0.46% | 36 |
|
|
2015
Q1 | $14.5M | Buy |
+107,777
| New | +$13.9M | 0.58% | 29 |
|
Other funds holding TMO
Swiss Life Asset Management's TMO Position: Q2 2026 in Review
Swiss Life Asset Management increased its Thermo Fisher Scientific (TMO) stake by 14% in Q2 2026, buying an estimated $3.58M and bringing the position to 60,525 shares worth $30.3M. The position accounts for 0.13% of the portfolio, ranked #135.
Swiss Life Asset Management first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $53.8M in Q2 2019. 1,901 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Swiss Life Asset Management held 60,525 shares of Thermo Fisher Scientific worth $30.3M as of Q2 2026.
- Swiss Life Asset Management bought 7,452 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.58M.
- Thermo Fisher Scientific made up 0.13% of Swiss Life Asset Management's portfolio in Q2 2026, its #135 holding.
- Swiss Life Asset Management first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
- Swiss Life Asset Management's Thermo Fisher Scientific position peaked at $53.8M in Q2 2019.
- 1,901 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.